25 results
DEFA14A
AEON
AEON Biopharma Inc. - Ordinary Shares
14 May 24
Additional proxy soliciting materials
9:14am
to certain performance goals in the review of BLAs. The FDA’s goal is to review standard applications within ten months after it accepts the application … , there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality
8-K/A
EX-99.7
45yvzl ha30v28i
11 Aug 23
Financial Statements and Exhibits
9:12pm
8-K
EX-14.1
ai94wkf7r6zlt
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-10.5
46euoq
27 Jul 23
Index to Financial Statements
5:28pm
8-K
12m y618y0
27 Jul 23
Index to Financial Statements
5:28pm
8-K
EX-99.1
z1do44ew
27 Jul 23
Index to Financial Statements
5:28pm